Arcturus Therapeutics Holdings, Inc. (ARCT)
12.03
-0.58
(-4.60%)
USD |
NASDAQ |
Oct 13, 16:00
12.25
+0.22
(+1.83%)
After-Hours: 04:27
Arcturus Therapeutics Holdings EPS Diluted (TTM) : -3.314 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.314 |
| March 31, 2026 | -2.816 |
| December 31, 2025 | -2.387 |
| September 30, 2025 | -2.464 |
| June 30, 2025 | -2.224 |
| March 31, 2025 | -2.524 |
| December 31, 2024 | -3.002 |
| September 30, 2024 | -2.213 |
| June 30, 2024 | -2.568 |
| March 31, 2024 | -3.908 |
| December 31, 2023 | -1.041 |
| September 30, 2023 | 3.614 |
| June 30, 2023 | 2.892 |
| March 31, 2023 | 4.054 |
| December 31, 2022 | 0.2449 |
| September 30, 2022 | -5.555 |
| June 30, 2022 | -6.276 |
| March 31, 2022 | -7.534 |
| December 31, 2021 | -7.741 |
| September 30, 2021 | -7.524 |
| June 30, 2021 | -6.386 |
| March 31, 2021 | -4.859 |
| December 31, 2020 | -3.385 |
| September 30, 2020 | -2.893 |
| June 30, 2020 | -2.540 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.060 |
| December 31, 2019 | -2.068 |
| September 30, 2019 | -1.405 |
| June 30, 2019 | -1.263 |
| March 31, 2019 | -2.187 |
| December 31, 2018 | -2.160 |
| September 30, 2018 | -2.176 |
| June 30, 2018 | -2.385 |
| March 31, 2018 | -2.305 |
| December 31, 2017 | -2.56 |
| September 30, 2017 | -3.99 |
| June 30, 2017 | -5.32 |
| March 31, 2017 | -5.88 |
| December 31, 2016 | -6.262 |
| September 30, 2016 | -6.122 |
| June 30, 2016 | -5.562 |
| March 31, 2016 | -5.772 |
| December 31, 2015 | -6.278 |
| September 30, 2015 | -8.378 |
| June 30, 2015 | -12.37 |
| March 31, 2015 | -14.68 |
| December 31, 2014 | -16.87 |
| September 30, 2014 | -17.01 |
| June 30, 2014 | -13.58 |
| March 31, 2014 | -10.64 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Emergent BioSolutions, Inc. | -3.554 |
| Exelixis, Inc. | 3.184 |
| Ionis Pharmaceuticals, Inc. | -3.473 |
| United Therapeutics Corp. | 27.96 |